Vir Biotechnology, Inc. Quarterly Current Ratio in % from Q2 2020 to Q2 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Vir Biotechnology, Inc. quarterly Current Ratio history and growth rate from Q2 2020 to Q2 2025.
  • Vir Biotechnology, Inc. Current Ratio for the quarter ending June 30, 2025 was 784 %, a 27.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 784 -304 -27.9% Jun 30, 2025
Q1 2025 898 -88.7 -8.98% Mar 31, 2025
Q4 2024 1.06K +326 +44.8% Dec 31, 2024
Q3 2024 1.05K +427 +68.9% Sep 30, 2024
Q2 2024 1.09K +484 +80.2% Jun 30, 2024
Q1 2024 987 +450 +83.7% Mar 31, 2024
Q4 2023 729 +239 +48.9% Dec 31, 2023
Q3 2023 620 +137 +28.3% Sep 30, 2023
Q2 2023 604 +177 +41.6% Jun 30, 2023
Q1 2023 537 +112 +26.3% Mar 31, 2023
Q4 2022 490 +75.1 +18.1% Dec 31, 2022
Q3 2022 483 +42.9 +9.75% Sep 30, 2022
Q2 2022 426 -82.5 -16.2% Jun 30, 2022
Q1 2022 426 -114 -21.1% Mar 31, 2022
Q4 2021 414 -483 -53.8% Dec 31, 2021
Q3 2021 440 -453 -50.7% Sep 30, 2021
Q2 2021 509 -281 -35.6% Jun 30, 2021
Q1 2021 539 Mar 31, 2021
Q4 2020 897 Dec 31, 2020
Q3 2020 892 Sep 30, 2020
Q2 2020 790 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.